Adenosine

In the US, Adenosine (adenosine systemic) is a member of the following drug classes: cardiac stressing agents, group V antiarrhythmics and is used to treat Supraventricular Tachycardia and Wolff-Parkinson-White Syndrome.

US matches:

• Adenosine

Scheme

USAN

ATC (Anatomical Therapeutic Chemical Classification)

C01EB10

CAS registry number (Chemical Abstracts Service)

0000058-61-7

Chemical Formula

C10-H13-N5-O4

Molecular Weight

267

Therapeutic Category

Antiarrhythmic agent

Chemical Names

6-Amino-9-beta-D-ribofuranosyl-9H-purin (IUPAC)

6-Amino-9-beta-D-ribofuranosyl-9H-purine (USAN)

9-beta-D-Ribofuranosyl-9H-purin-6-amine

9-beta-D-Ribofuranosyl-9H-purin-6-ylamin

9-beta-D-Ribofuranosyladenine (USAN)

9-(beta-D-Ribofuranosyl)-9H-adenin

Adenosine (USAN)

Foreign Names

• Adenosinum (Latin)
• Adenosin (German)
• Adénosine (French)
• Adenosina (Spanish)

Generic Names

• Adenosine (OS: USAN, BAN)
• Adenin riboside (IS)
• Adenocard (IS: Fujisawa)
• Adenoscan (IS: Fujisawa)
• Ado (IS)
• SR 96225 (IS)
• Adenosin (PH: Ph. Eur. 6)
• Adenosine (PH: BP 2010, Ph. Eur. 6, USP 32)
• Adénosine (PH: Ph. Eur. 6)
• Adenosinum (PH: Ph. Eur. 6)

Brand Names

• Adenocard
  Astellas, Canada; Astellas, United States; Libbs, Brazil



• Adenocor
  Aventis, Ireland; Aventis, New Zealand; Glaxo Wellcome, Poland; GlaxoSmithKline, Romania; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Bahrain; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Denmark; Sanofi-Aventis, Estonia; Sanofi-Aventis, Finland; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Hungary; Sanofi-Aventis, Israel; Sanofi-Aventis, Malta; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Norway; Sanofi-Aventis, Peru; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovakia; Sanofi-Aventis, Thailand; Sanofi-Synthelabo, Greece; Sanofi-Synthelabo, Luxembourg; Sanofi-Synthelabo, South Africa



• Adenoject
  Sun, India



• Adenoscan
  Astellas, United States; Asubio Pharma, Japan; Sanofi-Aventis, Australia; Sanofi-Aventis, Germany; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Italy; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Aventis S.A., Spain



• Adénoscan
  Sanofi-Aventis, France



• Adenosin Ebewe
  Ebewe, Austria; Ebewe, Czech Republic; Ebewe, Vietnam



• Adenosin Item
  Item, Norway



• Adenosin Life Medical
  Carinopharm, Germany; Life Medical, Denmark; Life Medical, Sweden



• Adenosina Biol
  Biol, Argentina



• Adenosine
  Akorn, United States; APP, United States; Baxter, United States; Bedford, United States; Gland, United States; Luitpold, United States; Sicor, United States; Strides, United States; Teva USA, United States; Wockhardt, United States



• Adesin
  Dae Han New Pharm, Vietnam



• Adrekar
  Sanofi-Aventis, Germany



• Atépadène
  Mayoly-Spindler, Tunisia



• Krenosin
  Sanofi-Aventis, Switzerland; Sanofi-Aventis, France; Sanofi-Aventis, Italy; Sanofi-Aventis, Mexico



• Tricor
  Sanofi-Aventis, Chile

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.